Earnings Due: Progress Software, Phreesia, and Neumora Therapeutics in Focus
Las Vegas, NV / CRWE PRESS RELEASE / March 29, 2026 - Several companies are preparing to report financial results on Monday, March 30, including:
Progress Software Corporation (Nasdaq: PRGS), an enterprise software provider known for its application development and infrastructure solutions, will release its fiscal first-quarter 2026 earnings after the market closes. Wall Street analysts expect earnings per share (EPS) of $1.57 on revenue of $246.4 million. On Friday, $PRGS dropped 5.14% (-$1.50) to close at $27.67.
Phreesia, Inc. (NYSE: PHR), a healthcare technology company focused on patient intake and engagement solutions, is scheduled to announce its fiscal fourth-quarter and full-year 2026 results after the close of trading. Analysts project EPS of $0.32 on revenue of $126.63 million. $PHR declined 5.75% (-$0.67) on Friday to finish at $10.98.
Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biotechnology company developing treatments for brain diseases, will report its fourth-quarter and full-year 2025 financials before the market opens. The consensus forecast calls for a loss of $0.33 per share. On Friday, $NMRA fell 6.43% (-$0.16) to end the session at $2.33.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
© 2026 CRWE PRESS RELEASE. All Rights Reserved.
